Bicycle Therapeutics

$10.16
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.41 (4.21%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours

Why Robinhood?

You can buy or sell BCYC and other stocks, options, ETFs, and crypto commission-free!

About BCYC

Bicycle Therapeutics plc American Depositary Shares, also called Bicycle Therapeutics, is a holding company, which engages in the development of biopharmaceuticals. It focuses on developing a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. Read More The firm utilizes its novel and proprietary phage display screening platform to identify bicycles. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom.

Employees
60
Headquarters
Cambridge, Cambridgeshire
Founded
2009
Market Cap
174.53M
Price-Earnings Ratio
Dividend Yield
Average Volume
32.57K
High Today
$10.52
Low Today
$9.82
Open Price
$9.82
Volume
19.85K
52 Week High
$14.91
52 Week Low
$6.24

Collections

BCYC Earnings

-$1.68
-$1.49
-$1.31
-$1.12
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 11, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.